RecruitingNot ApplicableNCT05933148

Network Neurofeedback Using 7-Tesla MRI to Reduce Rumination Levels in Depression

Network-based Real-time Neurofeedback Using Ultra-high Field MRI to Reduce Rumination Levels in Depression


Sponsor

Icahn School of Medicine at Mount Sinai

Enrollment

80 participants

Start Date

Jul 12, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Patients with major depressive disorder (MDD) exhibit increased levels of rumination (i.e. repetitive thinking and focus on negative mood states) which have been found to increase the risk of depressive relapse. The ability to reduce rumination levels among these patients is greatly needed. Rumination is known to be associated with the default mode network (DMN) region activity. Implementing the Dependency Network Analysis (DEPNA), a recently developed method by the research team to quantify the connectivity influence of network nodes, found that rumination was significantly associated with lower connectivity influence of the left medial orbitofrontal cortex (MOFC) on the right precuneus, both key regions within the DMN. This study implements the first real-time fMRI neurofeedback (Rt-fMRI-NF) network-based protocol for up-regulation of the MOFC influence on the precuneus in patients with MDD to reduce rumination levels. This will allow for more accurate explicit brain connections modulation than the standard single brain region activity; creating a larger opportunity for target clinical neuromodulation treatment in individuals with MDD.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a brain training technique called neurofeedback using a powerful 7-Tesla MRI scanner to help people with depression reduce rumination — the tendency to dwell repeatedly on negative thoughts. Participants receive real-time feedback about their brain activity to help change these patterns. **You may be eligible if...** - You are aged 18–65 - You have been diagnosed with major depressive disorder (MDD) with a current depressive episode, OR you have no psychiatric diagnosis at all (as a healthy control) - You can understand and communicate in English - You can participate in the full informed consent process **You may NOT be eligible if...** - You have a history of schizophrenia, psychotic disorder, neurodevelopmental disorder, or active substance use disorder in the past 6 months - You have unstable medical conditions or take medications that interfere with MRI or brain activity - You have metal implants or other MRI contraindications Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICESiemens 7T MRI

The active neurofeedback session will be done within the 7T MRI.

DEVICESham Neurofeedback

The sham Neurofeedback resembles the active condition but participants will not see their own brain activity and will instead view a past participant's active feedback from their same population group.


Locations(1)

Icahn School Of Medicine at Mount Sinai

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05933148


Related Trials